Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Added on Sunday, January 01, 2012
Status changed on Sunday, January 01, 2012 to: No maintenance for this code
BETOS Classification: Chemotherapy
Medicare coverage status: Special coverage instructions apply
